The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
Abstract
Transient worsening of tuberculous symptomatology and lesions following antituberculous therapy (paradoxical response) has previously been described as a rare occurrence. To determine the incidence of paradoxical responses in patients with AIDS and TB who are treated with antituberculous therapy and subsequently with combination antiretroviral therapy (ARV), we conducted a prospective study of 33 HIV-seropositive TB patients treated with anti-TB therapy and antiretroviral therapy (Group 1) compared with 55 HIV-seronegative TB patients treated with anti-TB therapy (Group 2) and 28 HIV-seropositive TB patients treated with anti-TB therapy but not on antiretrovirals (historical control; Group 3). In Group 1 patients, paradoxical responses were temporally more related to the initiation of ARV than to the initiation of anti-TB therapy (mean ± SD: 15 ± 11 d versus 109 ± 72 d [p < 0.001]) and occurred much more frequently (12 of 33; 36%) compared with Group 2 (1 of 55; 2%) (p < 0.001) or with Group 3 (2 of 28; 7%) (p = 0.013). The majority of patients who experienced paradoxical responses and received tuberculin purified protein derivative (PPD) in Group 1 had their tuberculin skin tests convert from negative to strongly positive after ARV. These observations suggest that a paradoxical response associated with enhanced tuberculin skin reactivity may occur after the initiation of ARV in HIV-infected TB patients. Furthermore, the skin test conversion after the initiation of ARV may have important public health implications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pathogenesis of PUR in patients with HIV infection and tuberculous lymphadenitis is more complex, because IRIS from newly initiated antiretroviral therapy (ART) also contributes to the exaggerated inflammatory response, as it does in pulmonary tuberculosis [54].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [54]
In the citing paper
“In addition, increased adenopathy has also been reported in 9%-11% of patients a mean of 27 months after successful treatment [5, 53].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [53]
In the citing paper
“Rates of PUR and/or IRIS have ranged from 22% to 60% in reported series involving HIV-positive patients treated for tuberculous lymphadenitis who have initiated ART [5, 54, 57].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [54]
In the citing paper
“Some authors report benefit [52, 53], but retrospective studies have shown that steroids did not prevent PUR in patients who received them from the onset of treatment [59] and had no effect on the duration of PUR [49, 50].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [53]
Citations
Cites
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
Goletti, D., Weissman, D., Jackson, R. W., Graham, N. M., Vlahov, D., Klein, R. S., Munsiff, S. S., Ortona, L., Cauda, R., & Fauci, A. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1271 · Cited by 495
Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection
Pape, J. W., Jean, S. S., Ho, J. L., Hafner, A., & Johnson, W. D. (1993) · The Lancet · doi:10.1016/0140-6736(93)91817-6 · Cited by 441
Whalen, C. C., Johnson, J. L., Okwera, A., Hom, D. L., Huebner, R., Mugyenyi, P., Mugerwa, R. D., Ellner, J. J., Nsubuga, P., Vjecha, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709183371201 · Cited by 396
Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
Jacobson, M. A., Zegans, M., Pavan, P. R., O'Donnell, J. J., Sattler, F., Rao, N., Owens, S., & Pollard, R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11431-8 · Cited by 366
Afghani, B., & Lieberman, J. M. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.6.1092 · Cited by 270
Suppressor Adherent Cells in Human Tuberculosis
Ellner, J. J. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.121.6.2573 · Cited by 222
Lymph node tuberculosis: A comparison of various methods of treatment
Campbell, I. A., & Dyson, A. J. (1977) · Tubercle · doi:10.1016/0041-3879(77)90041-1 · Cited by 189
Zhang, Y., Nakata, K., Weiden, M., & Rom, W. N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117924 · Cited by 182
French, M. A. H., Mallal, S. A., & Dawkins, R. L. (1992) · AIDS · doi:10.1097/00002030-199211000-00009 · Cited by 161
I. Weitere Mittheilungen über ein Heilmittel gegen Tuberculose
Koch, R. (1890) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1207546 · Cited by 150
Research works printed but not linked: 1
- Narita, 1997, Transient worsening of systemic signs and symptoms after antiretroviral therapy in patients with tuberculosis and AIDS (abstract)., Am. J. Respir. Crit. Care Med., 155, A255
Cited by
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
Havlir, D. V., & Barnes, P. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400507 · Cited by 1,461
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Metadata
- Authors
- NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E.
- Affiliations
- University of Miami (US)
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-07-01
- Volume
- 158
- Issue
- 1
- Pages
- 157-161
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2144781706
- Cited by
- 608
- References
- 22
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 3 · 2021: 8 · 2020: 19 · 2019: 13 · 2018: 5 · 2017: 18 · 2016: 14 · 2015: 13 · 2014: 18 · 2013: 21 · 2012: 19
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- paradoxical reaction, tuberculosis, AIDS, HIV infection, antiretroviral therapy, tuberculosis treatment, tuberculin skin test, purified protein derivative, tuberculin skin test conversion, tuberculosis reactivation
- MeSH terms
- Acquired Immunodeficiency Syndrome, Adult, Cell Count, Humans, Immunosuppression Therapy, Middle Aged, Tuberculin Test, Tuberculosis, Pulmonary, CD4 Antigens, Disease Progression, Anti-HIV Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS. https://app.cochat.ai/papers/10.1164/ajrccm.158.1.9712001
- The paper
- NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E. (1998). Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.158.1.9712001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.